The investment recognizes Wayspring's impactful approach to managing populations with SUD, showcasing the need for innovative care models. Existing investors including Valtruis (portfolio company of Welsh, Carson, Anderson & Stowe), HLM Venture Partners, and .406 Ventures all participated in the funding round.

Wayspring is a value-based healthcare organization that provides medical, behavioral health, and social support services to people with complex needs. With a focus on people living with substance use disorder, Wayspring utilizes a comprehensive and longitudinal model that incorporates targeted member outreach, strategic provider partnerships, community-based peer support, and delivery of clinical services. Through this unique approach, Wayspring produces increased adherence to evidence-based medicine, decreased healthcare waste, and improved health outcomes.